These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28177915)

  • 1. Fibrinogen is related to long-term mortality in Chinese patients with acute coronary syndrome but failed to enhance the prognostic value of the GRACE score.
    Peng Y; Xia TL; Li YM; Huang FY; Chai H; Wang PJ; Liu W; Zhang C; Pu XB; Chen SJ; Chen M; Huang DJ
    Oncotarget; 2017 Mar; 8(13):20622-20629. PubMed ID: 28177915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.
    Liu XJ; Wan ZF; Zhao N; Zhang YP; Mi L; Wang XH; Zhou D; Wu Y; Yuan ZY
    Cardiovasc Diabetol; 2015 Aug; 14():110. PubMed ID: 26285575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Admission Serum Calcium Levels Improve the GRACE Risk Score Prediction of Hospital Mortality in Patients With Acute Coronary Syndrome.
    Yan SD; Liu XJ; Peng Y; Xia TL; Liu W; Tsauo JY; Xu YN; Chai H; Huang FY; Chen M; Huang DJ
    Clin Cardiol; 2016 Sep; 39(9):516-23. PubMed ID: 27279131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
    Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in type-2 diabetes mellitus.
    Li WP; Neradilek MB; Gu FS; Isquith DA; Sun ZJ; Wu X; Li HW; Zhao XQ
    Cardiovasc Diabetol; 2017 Apr; 16(1):45. PubMed ID: 28381225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of admission blood glucose for all-cause mortality in patients with acute coronary syndromes: added value on top of GRACE risk score.
    Timóteo AT; Papoila AL; Rio P; Miranda F; Ferreira ML; Ferreira RC
    Eur Heart J Acute Cardiovasc Care; 2014 Sep; 3(3):257-63. PubMed ID: 24687188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of low admission hemoglobin over the GRACE score in patients with acute coronary syndrome.
    Moady G; Iakobishvili Z; Beigel R; Shlomo N; Matetzky S; Zahger D; Atar S
    J Cardiol; 2019 Apr; 73(4):271-275. PubMed ID: 30591318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive impact on medium-term mortality of hematological parameters in Acute Coronary Syndromes: added value on top of GRACE risk score.
    Timóteo AT; Papoila AL; Lousinha A; Alves M; Miranda F; Ferreira ML; Ferreira RC
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):172-9. PubMed ID: 25122727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prognostic significance between serum fibrinogen and Global Registry of Acute Coronary Events score for prognosis of patients with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Song J; Yu T; Sun Z; Li Z; He D; Sun Z
    Coron Artery Dis; 2020 Mar; 31(2):124-129. PubMed ID: 31833946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving risk stratification in non-ST-segment elevation myocardial infarction with combined assessment of GRACE and CRUSADE risk scores.
    Paiva L; Providência R; Barra SN; Dinis P; Faustino AC; Costa M; Gonçalves L
    Arch Cardiovasc Dis; 2014 Dec; 107(12):681-9. PubMed ID: 25219759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaemia to predict outcome in patients with acute coronary syndromes.
    Ennezat PV; Maréchaux S; Pinçon C; Finzi J; Barrailler S; Bouabdallaoui N; Van Belle E; Montalescot G; Collet JP
    Arch Cardiovasc Dis; 2013; 106(6-7):357-65. PubMed ID: 23806304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study).
    Fox KA; Carruthers KF; Dunbar DR; Graham C; Manning JR; De Raedt H; Buysschaert I; Lambrechts D; Van de Werf F
    Eur Heart J; 2010 Nov; 31(22):2755-64. PubMed ID: 20805110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between admission plasma fibrinogen levels and mortality in Chinese patients with coronary artery disease.
    Peng Y; Wang H; Li YM; Huang BT; Huang FY; Xia TL; Chai H; Wang PJ; Liu W; Zhang C; Chen M; Huang DJ
    Sci Rep; 2016 Jul; 6():30506. PubMed ID: 27456064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRACE score predicts heart failure admission following acute coronary syndrome.
    McAllister DA; Halbesma N; Carruthers K; Denvir M; Fox KA
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):165-71. PubMed ID: 24986419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved predictive value of GRACE risk score combined with platelet reactivity for 1-year cardiovascular risk in patients with acute coronary syndrome who underwent coronary stent implantation.
    Li S; Liu H; Liu J; Wang H
    Platelets; 2016 Nov; 27(7):650-657. PubMed ID: 27809713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-to-Lymphocyte Ratio Improves the Predictive Power of GRACE Risk Score for Long-Term Cardiovascular Events in Patients with Acute Coronary Syndrome.
    Zhou D; Fan Y; Wan Z; Wen W; Wang X; Zhou J; Chen T; Yuan Z
    Cardiology; 2016; 134(1):39-46. PubMed ID: 26866504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of the neutrophil-to-lymphocyte ratio and the GRACE risk score better predicts PCI outcomes in Chinese Han patients with acute coronary syndrome.
    Zhou D; Wan Z; Fan Y; Zhou J; Yuan Z
    Anatol J Cardiol; 2015; 15(12):995-1001. PubMed ID: 26663224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome.
    Widera C; Pencina MJ; Meisner A; Kempf T; Bethmann K; Marquardt I; Katus HA; Giannitsis E; Wollert KC
    Eur Heart J; 2012 May; 33(9):1095-104. PubMed ID: 22199121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention.
    Bai XF; Zhang YP; Zhou J; Wu Y; Li RF; Sun LZ; Ma QQ; Lou BW; Zhai BW; Liu MP; Cheng LL; Tong XN; Yuan ZY
    Thromb Res; 2018 Oct; 170():142-147. PubMed ID: 30193195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.